Salomon DS - Search Results

1

CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.

Normanno N, De Luca A, Maiello MR, Bianco C, Mancino M, Strizzi L, Arra C, Ciardiello F, Agrawal S, Salomon DS. Normanno N, et al. Among authors: salomon ds. Int J Oncol. 2004 Oct;25(4):1013-20. Int J Oncol. 2004. PMID: 15375551

2

Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.

D'Antonio A, Losito S, Pignata S, Grassi M, Perrone F, De Luca A, Tambaro R, Bianco C, Gullick WJ, Johnson GR, Iaffaioli VR, Salomon DS, Normanno N. D'Antonio A, et al. Among authors: salomon ds. Int J Oncol. 2002 Nov;21(5):941-8. Int J Oncol. 2002. PMID: 12370739

3

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.

Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS. Normanno N, et al. Among authors: salomon ds. J Cell Physiol. 2004 Jan;198(1):31-9. doi: 10.1002/jcp.10375. J Cell Physiol. 2004. PMID: 14584041

4

Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line.

Normanno N, Selvam MP, Bianco C, Damiano V, de Angelis E, Grassi M, Magliulo G, Tortora G, Salomon DS, Ciardiello F. Normanno N, et al. Among authors: salomon ds. Int J Cancer. 1995 Sep 15;62(6):762-6. doi: 10.1002/ijc.2910620619. Int J Cancer. 1995. PMID: 7558427

5

Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.

De Luca A, Selvam MP, Sandomenico C, Pepe S, Bianco AR, Ciardiello F, Salomon DS, Normanno N. De Luca A, et al. Among authors: salomon ds. Int J Cancer. 1997 Oct 9;73(2):277-82. doi: 10.1002/(sici)1097-0215(19971009)73:2<277::aid-ijc19>3.0.co;2-c. Int J Cancer. 1997. PMID: 9335455

6

Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.

Normanno N, De Luca A, Salomon DS, Ciardiello F. Normanno N, et al. Among authors: salomon ds. Cancer Detect Prev. 1998;22(1):62-7. Cancer Detect Prev. 1998. PMID: 9466051 Review.

7

De Luca A, Casamassimi A, Selvam MP, Losito S, Ciardiello F, Agrawal S, Salomon DS, Normanno N. De Luca A, et al. Among authors: salomon ds. Int J Cancer. 1999 Feb 9;80(4):589-94. doi: 10.1002/(sici)1097-0215(19990209)80:4<589::aid-ijc17>3.0.co;2-d. Int J Cancer. 1999. PMID: 9935161

8

Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families.

De Angelis E, Grassi M, Gullick WJ, Johnson GR, Rossi GB, Tempesta A, De Angelis F, De Luca A, Salomon DS, Normanno N. De Angelis E, et al. Among authors: salomon ds. Int J Oncol. 1999 Mar;14(3):437-40. doi: 10.3892/ijo.14.3.437. Int J Oncol. 1999. PMID: 10024674

9

EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.

Casamassimi A, De Luca A, Agrawal S, Stromberg K, Salomon DS, Normanno N. Casamassimi A, et al. Among authors: salomon ds. Ann Oncol. 2000 Mar;11(3):319-25. doi: 10.1023/a:1008350811639. Ann Oncol. 2000. PMID: 10811499 Free article.

10

Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.

De Luca A, Arra C, D'Antonio A, Casamassimi A, Losito S, Ferraro P, Ciardiello F, Salomon DS, Normanno N. De Luca A, et al. Among authors: salomon ds. Oncogene. 2000 Nov 30;19(51):5863-71. doi: 10.1038/sj.onc.1203979. Oncogene. 2000. PMID: 11127817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters